Statement of Kenneth Stein, M.D., Chief Medical Officer, Cardiac Rhythm Management, Boston Scientific on JAMA Article(2)January 4, 2011 12:35 pm | by Boston Scientific | Comments
NATICK, Mass., Jan. 4, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today issued the following statement from Kenneth Stein, M.D., Chief Medical Officer, Cardiac Rhythm Management, on an article that was pub
Statement of Kenneth Stein, M.D., Chief Medical Officer, Cardiac Rhythm Management, Boston Scientific on JAMA ArticleJanuary 4, 2011 12:34 pm | Comments
NATICK, Mass., Jan. 4, 2011 / PRNewswire / -- Boston Scientific Corporation (NYSE: BSX) today issued the following statement from Kenneth Stein, M.D., Chief Medical Officer, Cardiac Rhythm Management, on an article that was pub
NATICK, Mass., Jan. 4, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the completion of its acquisition of Sadra Medical, Inc. of Los Gatos, California. Â The transaction follows the definitive
(International Association for the Study of Lung Cancer) Online registration opens today for the 14th World Conference on Lung Cancer, the world's largest meeting dedicated to lung and thoracic cancers.
Strategic transaction greatly expands ON Semiconductor?s presence in Japan and is expected to further the company?s growth on a global basis.
A stack of punch cards from a landmark study published in 1966, and the legwork to track down the study's participants years later, has yielded the longest analysis of the effects of lipoproteins on coronary heart disease. The study tracked almost 1,900 people over a 29-year period, which...
Angstron Materials Inc., announced the world?s first commercial graphene application. The ongoing development of touch screens for consumer electronics is driving a growing need for sense data.
Momenta Pharmaceuticals Inc. has appointed Young T. Kwon, former senior director of business development at Biogen Idec, as vice president of business development of the company.
Constellation Pharmaceuticals Inc. has named Eli Lilly and Company veteran James Audia as chief scientific officer of the Cambridge genome-focused drug developer.
Foundation Medicine Inc., a cancer diagnostics startup, has inked a collaboration deal with Swiss drug giant Novartis AG to tailor Foundation's genome-based tests to Novartis' needs.
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, is scheduled to present at the J.P. Morgan Healthcare Conference at the Westin St. Francis in San Francisco, California on Tuesday, January 11, 2011.Michael A. Mussallem,...
FLORHAM PARK, N.J., Jan. 4, 2011 /- Managed Health Care Associates, Inc. (MHA), a leading healthcare service company focused on alternate site providers, is pleased to announce the acquisition of Navigator, Inc., Nashville, TN. Navigator is one of the nation's largest and fastest growing...
Philadelphia's Victoria A. Cirillo-Hyland, M.D. Adds Alma Lasers' Pixel CO2 Laser System to Offer Fractional CO2 Laser Treatments to PatientsJanuary 4, 2011 7:36 am | by Bio-Medicine.Org | Comments
BRYN MAWR, Pa., Jan. 4, 2011 /- Owner and medical director of Cirillo Cosmetic Dermatology Spa, Victoria A. Cirillo-Hyland, M.D., has expanded her practice and is now offering Pixel Perfect™ treatments to her patients with the purchase of the Pixel CO2 laser from Alma Lasers. "I'm...
CHADDS FORD, Pa., Jan. 4, 2011 /- Endo Pharmaceuticals (Nasdaq: ENDP ) today announced that it will present at the J.P. Morgan 29th Annual Healthcare Conference on Monday, January 10, 2011 at 1:30 p.m. PT. David P. Holveck, president and CEO of Endo, will review the company's...